University of Utah, Salt Lake City, UT 84132, USA.
Am J Emerg Med. 2013 Feb;31(2):313-8. doi: 10.1016/j.ajem.2012.08.009. Epub 2012 Sep 13.
The aim of this study was to evaluate the incidence of anxiety and rates of anxiety treatment in emergency department (ED) patients presenting with pain-related complaints.
We prospectively evaluated patients in an urban academic tertiary care hospital ED from 2000 through 2010. We enrolled a convenience sample of adult patients presenting with pain and recorded patient complaint, medication administration, satisfaction, and pain and anxiety scores throughout their stay. We stratified patients into 4 different groups according to anxiety score at presentation (0, none; 1-4, mild; 5-7, moderate; 8-10, severe).
We enrolled 10 664 ED patients presenting with pain-related complaints. Patients reporting anxiety were as follows: 25.7%, none; 26.1%, mild; 23.7%, moderate; and 24.5%, severe. Although 48% of patients described moderate to severe anxiety at ED presentation and 60% were willing to take a medication for anxiety, only 1% received anxiety treatment. Thirty-five percent of patients still reported moderate/severe anxiety at discharge. Severe anxiety at ED presentation was associated with increased demand for pain medication (odds ratio [OR], 1.40; 95% confidence interval [CI], 1.10-1.79) and anxiety medication (OR, 4.34; 95% CI, 3.68-5.11) during the ED stay and decreased satisfaction with the treatment of pain (β coefficient = -0.328; P < .001). After adjusting for age, sex, and presentation pain scores, patients who reported severe anxiety were more likely to receive an analgesic (OR, 1.33; 95% CI, 1.19-1.50) and an opioid (OR, 1.25; 95% CI, 1.11-1.41) during the ED stay.
Anxiety may be underrecognized and undertreated in patients presenting with pain-related complaints. Patients reporting severe anxiety were less likely to report satisfaction with the treatment of their pain, despite higher rates of analgesic administration.
本研究旨在评估急诊科(ED)因疼痛就诊患者的焦虑发生率和焦虑治疗率。
我们前瞻性评估了 2000 年至 2010 年期间一家城市学术性三级保健医院 ED 的患者。我们纳入了便利抽样的成年疼痛患者,记录患者就诊时的主诉、用药、满意度以及疼痛和焦虑评分。我们根据就诊时的焦虑评分将患者分为 4 个不同组(0 分,无;1-4 分,轻度;5-7 分,中度;8-10 分,重度)。
我们共纳入 10664 例因疼痛相关主诉就诊的 ED 患者。报告有焦虑的患者为:25.7%,无;26.1%,轻度;23.7%,中度;24.5%,重度。尽管 48%的患者在 ED 就诊时报告中至重度焦虑,60%愿意服用焦虑治疗药物,但仅有 1%接受了焦虑治疗。35%的患者在出院时仍报告有中至重度焦虑。ED 就诊时重度焦虑与 ED 期间对疼痛治疗药物(比值比[OR],1.40;95%置信区间[CI],1.10-1.79)和焦虑治疗药物(OR,4.34;95%CI,3.68-5.11)的需求增加相关,并且对疼痛治疗的满意度降低(β系数=-0.328;P<.001)。在调整年龄、性别和就诊时疼痛评分后,报告有重度焦虑的患者更有可能在 ED 期间接受镇痛剂(OR,1.33;95%CI,1.19-1.50)和阿片类药物(OR,1.25;95%CI,1.11-1.41)。
在因疼痛相关主诉就诊的患者中,焦虑可能未被充分识别和治疗。尽管接受了更高剂量的镇痛药物,但报告有重度焦虑的患者更有可能对疼痛治疗的满意度降低。